---
title: "Evolv Launches Evolv Grow, a Next-Generation Oral GHK-Cu Hair Growth Supplement for Men and Women Powered by EV2 Peptide™"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291576017.md"
description: "The new Evolv Grow product has been launched after a 12-week study. It is now being sold on EvolvLife.com and at the Equinox Hotel Spa in New York City. The study was conducted with a placebo as a control. The wellness company Evolv, known for its development of the first orally bioavailable GLP-1 biomimetic peptide, made the announcement on July 2, 2026, in New York."
datetime: "2026-07-02T17:22:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291576017.md)
  - [en](https://longbridge.com/en/news/291576017.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291576017.md)
generator: "portal-rs"
---

# Evolv Launches Evolv Grow, a Next-Generation Oral GHK-Cu Hair Growth Supplement for Men and Women Powered by EV2 Peptide™

The new Evolv Grow product has been launched after a 12-week study. It is now being sold on EvolvLife.com and at the Equinox Hotel Spa in New York City. The study was conducted with a placebo as a control. The wellness company Evolv, known for its development of the first orally bioavailable GLP-1 biomimetic peptide, made the announcement on July 2, 2026, in New York.

### Related Stocks

- [EVLV.US](https://longbridge.com/en/quote/EVLV.US.md)

## Related News & Research

- [Evolv Technologies director Michael Ellenbogen sells 80,752 shares for $451,403.68](https://longbridge.com/en/news/296395204.md)
- [Evolv director Henrik Kuhl acquires 15,000 shares valued at $85,950](https://longbridge.com/en/news/296264842.md)
- [Young female investors’ pots ‘nearly £4,600 bigger than those belonging to men’](https://longbridge.com/en/news/296154079.md)
- [08:36 ETUltimate Men's HQ Launches Private Product-Match Education Experience](https://longbridge.com/en/news/296789283.md)
- [Quest Diagnostics teams with Humanity to offer biological age analysis on Questhealth.com](https://longbridge.com/en/news/296926398.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**